TrialJournal of clinical immunology2025

Efficacy, Safety, Tolerability, and Serum IgG Trough Levels of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% in US Pediatric Patients with Primary Immunodeficiency Diseases.

Niraj C Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.